Sehhoon Park

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Cerebrospinal Fluid

Tyrosine Kinase

Artificial Intelligence

Top Venues

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jeanne Shen, Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W Dulken, Stephanie Bogdan, Maggie Huang, George A Fisher, Sehhoon Park, Se-Hoon Lee, Jun-Eul Hwang, Jin-Haeng Chung, Leeseul Kim, Heon Song, Sergio Pereira, Seunghwan Shin, Yoojoo Lim, Chang Ho Ahn, Seulki Kim, Chiyoon Oum, Sukjun Kim, Gahee Park, Sanghoon Song, Wonkyung Jung, Seokhwi Kim, Yung-Jue Bang, Tony S K Mok, Siraj M Ali, Chan-Young Ock
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. Journal for immunotherapy of cancer 12 (2) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Jeanne Shen, Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W Dulken, Stephanie Bogdan, Maggie Huang, George A Fisher, Sehhoon Park, Se-Hoon Lee, Jun-Eul Hwang, Jin-Haeng Chung, Leeseul Kim, Heon Song, Sergio Pereira, Seunghwan Shin, Yoojoo Lim, Chang Ho Ahn, Seulki Kim, Chiyoon Oum, Sukjun Kim, Gahee Park, Sanghoon Song, Wonkyung Jung, Seokhwi Kim, Yung-Jue Bang, Tony S K Mok, Siraj M Ali, Chan-Young Ock
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. Journal for immunotherapy of cancer 12 (2) (2024)
Jeanne Shen, Yoon-La Choi, Taebum Lee, Hyojin Kim, Young Kwang Chae, Ben W Dulken, Stephanie Bogdan, Maggie Huang, George A Fisher, Sehhoon Park, Se-Hoon Lee, Jun-Eul Hwang, Jin-Haeng Chung, Leeseul Kim, Heon Song, Sergio Pereira, Seunghwan Shin, Yoojoo Lim, Chang Ho Ahn, Seulki Kim, Chiyoon Oum, Sukjun Kim, Gahee Park, Sanghoon Song, Wonkyung Jung, Seokhwi Kim, Yung-Jue Bang, Tony S K Mok, Siraj M Ali, Chan-Young Ock
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. Journal for immunotherapy of cancer 12 (2) (2024)
Hyojin Kim, Seokhwi Kim, Sangjoon Choi, Changhee Park, Seonwook Park, Sergio Pereira, Minuk Ma, Donggeun Yoo, Kyunghyun Paeng, Wonkyung Jung, Sehhoon Park, Chan-Young Ock, Se-Hoon Lee, Yoon-La Choi, Jin-Haeng Chung
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Hyojin Kim, Seokhwi Kim, Sangjoon Choi, Changhee Park, Seonwook Park, Sergio Pereira, Minuk Ma, Donggeun Yoo, Kyunghyun Paeng, Wonkyung Jung, Sehhoon Park, Chan-Young Ock, Se-Hoon Lee, Yoon-La Choi, Jin-Haeng Chung
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sehhoon Park, Richard Baldry, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Yu Jung Kim, Young Joo Lee, Dong Wan Kim, Sang-We Kim, Ki Hyeong Lee, Won Jae Lee, Jung Won Choi, Kyuha Chong, Jung-Il Lee, So-Hyeon Gwon, Nak-Hoon Son, Myung-Ju Ahn
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Jaeyun Jung, You Jeong Heo, Sehhoon Park
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. Journal for immunotherapy of cancer 11 (4) (2023)
Sehhoon Park, Yu Jung Kim, Young Joo Min, Peter G S Mortimer, Hee-Jung Kim, Simon A Smith, Emma Dean, Hyun Ae Jung, Jong-Mu Sun, Woong-Yang Park, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon Lee, Keunchil Park
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer. Cancer (2023)
Jaeyun Jung, You Jeong Heo, Sehhoon Park
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. Journal for immunotherapy of cancer 11 (4) (2023)
Jaeyun Jung, You Jeong Heo, Sehhoon Park
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. Journal for immunotherapy of cancer 11 (4) (2023)
Sehhoon Park, Tae Min Kim, Ji-Youn Han, Gyeong-Won Lee, Byoung Yong Shim, Yun-Gyoo Lee, Sang-We Kim, Il Hwan Kim, Suee Lee, Yu Jung Kim, Ji Hyun Park, Sang-Gon Park, Ki Hyeong Lee, Eun Joo Kang, Ju Won Kim, Seong Hoon Shin, Chan-Young Ock, Byung-Ho Nam, Jaebong Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
A Phase 3, Randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR or ALK mutated in non-small cell lung cancer (ATTLAS, KCSG-LU19-04). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jaeyun Jung, You Jeong Heo, Sehhoon Park
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. Journal for immunotherapy of cancer 11 (4) (2023)
Yong Jae Kwon, Young Cheol Yoon, Hyun Su Kim, Min Jae Cha, Sehhoon Park, Ji Hyun Lee
Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle status. Journal of cachexia, sarcopenia and muscle (2023)
Jaeyun Jung, You Jeong Heo, Sehhoon Park
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. Journal for immunotherapy of cancer 11 (4) (2023)
Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S K Mok, Se-Hoon Lee
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)